- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07586111
Effects of Plant Foods on Gastrointestinal and Cardiometabolic Health (PLANTIFUL)
A Randomised Controlled Trial Investigating the Impact of Plant Foods on Gastrointestinal and Cardiometabolic Health
The aim of this randomised controlled trial is to investigate the effects of plant foods on gastrointestinal and cardiometabolic health in healthy adults aged 30-70 years old. The main question it will answer is "what is the effect of plant foods on alpha-diversity of the gut microbiota?".
Researchers will compare two diets containing plant foods to see if they have different effects on gastrointestinal and cardiometabolic health.
Participants will be asked to replace all their meals, snacks and drinks with those provided by the study team for four weeks (6 days/week). Participants will also be asked to attend the research facility on three occasions to:
- Provide a blood sample
- Provide a urine sample
- Provide a stool sample
- Have their body composition assessed
- Have an ultrasound of their artery (arm)
- Have their blood pressure measured
- Answer questionnaires related to dietary intake, mental health, physical activity, quality of life, diet acceptability and adherence
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
London, Spojené království, SE1 9NH
- Nábor
- King's College London
-
Kontakt:
- Clinical Trial Manager
- Telefonní číslo: +442078484552
- E-mail: plantiful@kcl.ac.uk
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Adults aged 30-70 years of age
- Capacity to give informed consent in English
- Consume equal or less than the average UK plant food intake (number and quantity)
- Consume less than 30 g/d of fibre
- BMI 18.50-29.99 kg/m2
- Willing to complete the trial by adhering to the diet intervention, complete questionnaires, provide stool, urine and blood samples, record weight and other anthropometric values and record food intake throughout the study
- Willing and able to adhere to the protocol for the diet intervention for the whole duration of the trial (e.g., appropriate space in freezer to store meals, access to oven/microwave, no planned travelling)
- Willing to discontinue use of prebiotics and probiotics 4 weeks prior and during the intervention period
- Willing to consume animal products daily
- Medication use is stable in women receiving hormone replacement therapy (stable use for the past 3 months)
Exclusion Criteria:
- Medical history of any of the following: diabetes, major active or historic psychiatric conditions (e.g., schizophrenia), current eating disorder, alcohol abuse, active treatment for cancer in the last year, severe neurological, endocrine, renal, cardiac or pulmonary disease (or any other chronic medical condition), severe oesophagitis, gastritis or duodenitis, active diverticulitis or intestinal/colonic strictures, Coeliac disease, Crohn's disease or Ulcerative colitis, stem cell or organ transplant, gut resection surgery (excluding appendicectomy and cholecystectomy), bleeding disorder, anaphylaxis or any other major or chronic condition known to impact study outcome measures.
- A current diagnosis of IBS, as defined by the Rome IV criteria.
- Taking medications known to affect outcomes of interest, including:
- Prebiotics and probiotics 4 weeks prior to enrolment.
- Antibiotics within 4 weeks of enrolment.
- Medications known to affect blood pressure, appetite, gut motility, glucose control, or lipid levels within 4 weeks of enrolment.
- Taking any dietary supplements, apart from vitamin D or calcium supplements, 4 weeks prior to enrolment.
- Allergy or intolerance to any study food ingredients.
- Unable/dislike/unwilling to consume study foods or adhere to study protocol (e.g., not willing to drink a maximum 9 units of alcohol a week or consume animal products).
- Currently reported pregnant or lactating.
- Unwilling or unable to consume non-halal or non-kosher products.
- Estimated energy requirements of <1,500 kcal/day or >3,000 kcal/day.
- Unexplained or unintentional weight loss in the past six months.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Trojnásobný
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Study Diet A
Meals, snacks and drinks that contain plant foods provided by the research team for four weeks (6 days a week).
|
Study meals, snacks and drinks will be provided that contain plant foods for four weeks (6 days a week).
Participants will follow guidance in self-selecting foods on one day per week.
Ostatní jména:
|
|
Aktivní komparátor: Study Diet B
Meals, snacks and drinks that contain plant foods provided by the research team for four weeks (6 days a week).
|
Study meals, snacks and drinks will be provided that contain plant foods for four weeks (6 days a week).
Participants will follow guidance in self-selecting foods on one day per week.
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Alpha-diversity of the gut microbiota
Časové okno: Week 4
|
The diversity of microbial taxa in faecal samples at 4 weeks assessed by calculating alpha-diversity score from 16S ribosomal RNA sequencing.
|
Week 4
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Absolute and change in alpha-diversity of the gut microbiota
Časové okno: Baseline, Week 4
|
Absolute and change in alpha-diversity as measured by the diversity of micriobial taxa in faecal samples via 16S RNA sequencing.
|
Baseline, Week 4
|
|
Beta-diversity of the gut microbiota
Časové okno: Baseline, Week 4
|
The diversity of microbial taxa in faecal samples by calculating beta-diversity via 16S ribosomal RNA sequencing.
|
Baseline, Week 4
|
|
Microbiota composition
Časové okno: Baseline, Week 4
|
Absolute and change in microbiota composition of faecal samples between baseline and Week 4 as assessed by 16S ribosomal RNA sequencing.
|
Baseline, Week 4
|
|
Targeted faecal and plasma metabolomics
Časové okno: Baseline, Week 4
|
Absolute and change in short-chain fatty acids through Liquid Chromatography - Mass Spectrometry using validated assays.
|
Baseline, Week 4
|
|
Targeted faecal and plasma metabolomics
Časové okno: Baseline, Week 4
|
Absolute and change in bile acids through Liquid Chromatography - Mass Spectrometry using validated assays.
|
Baseline, Week 4
|
|
Untargeted faecal metabolomics
Časové okno: Baseline, Week 4
|
Metabolomics analysis via 1H NMR spectroscopy.
|
Baseline, Week 4
|
|
Faecal water content via oven drying
Časové okno: Baseline, Week 4
|
Absolute and change in water content of faecal samples assessed via oven drying.
|
Baseline, Week 4
|
|
Stool frequency
Časové okno: Baseline, Week 4
|
Absolute and change in stool frequency measured via prospective 7-day stool diary
|
Baseline, Week 4
|
|
Stool consistency
Časové okno: Baseline, Week 4
|
Absolute and change in stool consistency measured by Bristol stool form scale. Scale from 1 to 7.
|
Baseline, Week 4
|
|
Gastrointestinal symptoms
Časové okno: Baseline, Week 4
|
Absolute and change in gastrointestincal symptons measured by Gastrointestinal symptoms rating scale score.
Scored from 15 to 105 with lower scores indicating less severe symptoms.
|
Baseline, Week 4
|
|
Endothelial function
Časové okno: Baseline, Week 4
|
Flow mediated dilation measured via ultrasound of arm.
|
Baseline, Week 4
|
|
Untargeted urine and plasma metabolomics
Časové okno: Baseline, Week 4
|
Metabolomics measured via 1H NMR spectroscopy.
|
Baseline, Week 4
|
|
Targeted plasma and urine metabolomics
Časové okno: Baseline, Week 4
|
Metabolomics via Liquid Chromatography-Mass Spectroscopy using validated assays.
|
Baseline, Week 4
|
|
Blood pressure
Časové okno: Baseline, Week 4
|
Absolute and change in diastolic and systolic blood pressure.
|
Baseline, Week 4
|
|
Body composition
Časové okno: Baseline, Week 4
|
Absolute and change in body composition measured via biolelectrical impedance analysis (BIA).
|
Baseline, Week 4
|
|
Waist circumference
Časové okno: Baseline, Week 4
|
Absolute and change in waist circumference assessed by tape measure.
|
Baseline, Week 4
|
|
Dietary intake
Časové okno: Baseline, Week 4
|
Dietary intake measured by aggregating EPIC Norfolk food frequency questionnaire, daily food and drink diaries and food checklists.
|
Baseline, Week 4
|
|
Biological markers of dietary intake
Časové okno: Baseline, Week 4
|
Absolute and change in biomarkers of dietary intake as measured via validated assays.
|
Baseline, Week 4
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Health-related Quality of Life
Časové okno: Baseline, Week 4
|
Absolute and change in SF-36 questionnaire scores.
|
Baseline, Week 4
|
|
Mental Health
Časové okno: Baseline, Week 4
|
Absolute and change in Patient Health Questionnaire-8 and Anxiety and Depression Scale scores.
|
Baseline, Week 4
|
|
Diet acceptability
Časové okno: Baseline, Week 4
|
Acceptability of diet measured through a diet acceptability questionnaire containing multiple choice and open-ended questions.
|
Baseline, Week 4
|
|
Diet satisfaction
Časové okno: Week 4
|
Absolute diet satisfaction measured by Food benefits assessment scale.
Scored from 41 to 205 with a lower score indicating a higher diet satisfaction.
|
Week 4
|
|
Dietary adherence
Časové okno: Baseline, Week 4
|
Adherence to the intervention as measured by consumption of study meals, snacks and drinks.
|
Baseline, Week 4
|
Spolupracovníci a vyšetřovatelé
Publikace a užitečné odkazy
Užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- HR-25/26-49752
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Zdraví dospělí dobrovolníci
-
3i SolutionsKGK Science Inc.Zatím nenabírámeBiologická dostupnost Heathy Volunteers | Farmakokinetické parametryKanada
-
Sarfez Pharmaceuticals, Inc.DokončenoBiologická dostupnost Heathy VolunteersSpojené státy
-
Sarfez Pharmaceuticals, Inc.DokončenoBiologická dostupnost Heathy VolunteersSpojené státy
-
Jiangsu HengRui Medicine Co., Ltd.DokončenoZdravý Cninese Adult MaleČína
-
Factors Group of Nutritional Companies Inc.IsuraDokončenoBezpečnost | Biologická dostupnost Heathy VolunteersKanada
-
National Research Council, SpainAktivní, ne náborBiologická dostupnost Heathy Volunteers | Biologická dostupnost a AUCŠpanělsko
-
Aziende Chimiche Riunite Angelini Francesco S.p.ASocraTec R&D GmbHDokončenoStudie biologické dostupnosti | Biologická dostupnost Heathy Volunteers | BioekvivalenceNěmecko
-
University of ZurichDokončenoOutcome Assessment, Health CareŠvýcarsko
-
University of BernUniversity Hospital Inselspital, BerneDokončenoNeuroscience of Dreaming, HealthŠvýcarsko
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development... a další spolupracovníciDokončenoPreventivní zdravotní služby (PREV HEALTH SERV)Spojené státy